Cd. Naylor et al., CESAREAN DELIVERY IN RELATION TO BIRTH-WEIGHT AND GESTATIONAL GLUCOSE-TOLERANCE - PATHOPHYSIOLOGY OR PRACTICE STYLE, JAMA, the journal of the American Medical Association, 275(15), 1996, pp. 1165-1170
Objectives.-To examine the relationship between birth weight and mode
of delivery among women with untreated borderline gestational diabetes
mellitus (GDM), treated overt GDM, and normoglycemia. Design.-Prospec
tive cohort study. Setting.-Three Toronto, Ontario, teaching hospitals
. Patients.-A total of 3778 volunteers aged 24 years or older. Interve
ntions.-Subjects underwent a 3-hour, 100-g oral glucose tolerance test
at 28 weeks' gestation, regardless of screening test results. Usual c
are was provided to 143 women who met the National Diabetes Data Group
criteria for GDM, Physicians were blinded to glucose test results for
all others, including 115 untreated women with borderline GDM by the
broader criteria of Carpenter and Coustan. Main Outcome Measures.-Crud
e and adjusted rates of cesarean delivery and neonatal macrosomia (bir
th weight >4000 g). Results.-Compared with normoglycemic controls, the
untreated borderline GDM group had increased rates of macrosomia (28.
7% vs 13.7%, P<.001) and cesarean delivery (29.6% vs 20.2%, P=.02). Ce
sarean delivery in this subgroup was associated with macrosomia (45.5%
vs 23.5%, P=.03). Usual care of known GDM normalized birth weights, b
ut the cesarean delivery rate was about 33% whether macrosomia was pre
sent or absent. A clearly increased risk of cesarean delivery among tr
eated patients compared with normoglycemic controls persisted after ad
justment for multiple maternal risk factors (adjusted odds ratio, 2.1;
95% confidence interval, 1.3 to 3.6). Conclusions.-Infant macrosomia
was a mediating factor in high cesarean delivery rates for women with
untreated borderline GDM, While detection and treatment of GDM normali
zed birth weights, rates of cesarean delivery remained inexplicably hi
gh. Recognition of GDM may lead to a lower threshold for surgical deli
very that mitigates the potential benefits of treatment.